Skip to main content
Erschienen in: Diabetology International 2/2019

28.08.2018 | Original Article

The revalidation of the diabetes treatment-related quality-of-life (DTR-QOL) questionnaire in Japan

verfasst von: Hitoshi Ishii, Hyunchung Ray Kim, Bruce Crawford

Erschienen in: Diabetology International | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The objectives of this study were to develop a conceptual framework for the diabetes treatment-related quality of life (DTR-QOL) and validate the new structure of the DTR-QOL.

Methods

This study was conducted in two stages. First, items were collated into similar concepts to develop a new conceptual framework for the DTR-QOL. Next, psychometric analyses were conducted. Analyses included a distribution of responses (and domains) with a focus on floor/ceiling effects, item convergent/discriminant validity, internal consistency reliability (where possible), clinical validity, known-group analysis, and concurrent validity with the Diabetes Treatment Satisfaction Questionnaire and SF-8. Known groups were evaluated using “Glycemic control in the last month”, “Concerned with weight gain in the last month”, “Current health status”, and “Degree of communication with clinician”. To evaluate the reliability of each scale, test–retest were assessed.

Results

The DTR-QOL items were reconstructed into seven domains based on similar concepts: usual activities, pain/discomfort, anxiety/depression, satisfaction, positive feelings, negative feelings, and feeling troubled. Although there were ceiling effects on most items, when patients reported having a hypoglycemic event in the last month, score distributions found fewer ceiling effects indicating that items are able to respond to clinical changes. Internal consistency reliability was met for all scales except satisfaction (α = 0.69) and pain/discomfort (α = 0.66). Clinical validity, known groups, and concurrent validity were met. Test–retest met acceptable levels for all scales except positive feelings.

Conclusions

The restructuring of the DTR-QOL resulted in an acceptable measure with domains that are easily interpreted and allow physicians to better measure more specific impacts on their patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Gæde P, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383–93.CrossRefPubMed Gæde P, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383–93.CrossRefPubMed
4.
Zurück zum Zitat de Climens AR, et al. Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapy. Curr Med Res Opin. 2015;31(4):643–65.CrossRef de Climens AR, et al. Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapy. Curr Med Res Opin. 2015;31(4):643–65.CrossRef
5.
Zurück zum Zitat Ishii H, et al. Improvement of glycemic control and quality-of-life by insulin lispro therapy: assessing benefits by ITR-QOL questionnaires. Diabetes Res Clin Pract. 2008;81(2):169–78.CrossRefPubMed Ishii H, et al. Improvement of glycemic control and quality-of-life by insulin lispro therapy: assessing benefits by ITR-QOL questionnaires. Diabetes Res Clin Pract. 2008;81(2):169–78.CrossRefPubMed
6.
Zurück zum Zitat Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–307.CrossRefPubMedPubMedCentral Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–307.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–24.CrossRefPubMed Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–24.CrossRefPubMed
8.
Zurück zum Zitat Biderman A, et al. Treatment satisfaction of diabetic patients: what are the contributing factors? Fam Pract. 2009;26(2):102–8.CrossRefPubMed Biderman A, et al. Treatment satisfaction of diabetic patients: what are the contributing factors? Fam Pract. 2009;26(2):102–8.CrossRefPubMed
9.
Zurück zum Zitat Ishii H. Development and psychometric validation of the diabetes therapy-related QOL (DTR-QOL) questionnaire. J Med Econ. 2012;15(3):556–63.CrossRefPubMed Ishii H. Development and psychometric validation of the diabetes therapy-related QOL (DTR-QOL) questionnaire. J Med Econ. 2012;15(3):556–63.CrossRefPubMed
10.
Zurück zum Zitat Rothman M, et al. Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO Task force report. Value Health. 2009;12(8):1075–83.CrossRefPubMed Rothman M, et al. Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO Task force report. Value Health. 2009;12(8):1075–83.CrossRefPubMed
11.
Zurück zum Zitat FDA. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.CrossRef FDA. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.CrossRef
12.
Zurück zum Zitat Patrick DL, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10(Suppl 2):S125–37.CrossRefPubMed Patrick DL, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10(Suppl 2):S125–37.CrossRefPubMed
13.
Zurück zum Zitat Ishii H, et al. Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study. Diabetol Metab Syndr. 2017;9:3.CrossRefPubMedPubMedCentral Ishii H, et al. Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study. Diabetol Metab Syndr. 2017;9:3.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Mashitani T, et al. Diabetes treatment-related quality of life is associated with levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes: diabetes distress and care registry at Tenri (DDCRT 8). Acta Diabetol. 2015;52(4):639–47.CrossRefPubMed Mashitani T, et al. Diabetes treatment-related quality of life is associated with levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes: diabetes distress and care registry at Tenri (DDCRT 8). Acta Diabetol. 2015;52(4):639–47.CrossRefPubMed
15.
Zurück zum Zitat Okada M, et al. Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus. J Pharm Health Care Sci. 2015;1:26.CrossRefPubMedPubMedCentral Okada M, et al. Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus. J Pharm Health Care Sci. 2015;1:26.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Ishii H, et al. The Japanese version of the diabetes treatment satisfaction questionnaire (DTSQ): translation and clinical evaluation. J Clin Exp Med. 2000;192(7):809–14. Ishii H, et al. The Japanese version of the diabetes treatment satisfaction questionnaire (DTSQ): translation and clinical evaluation. J Clin Exp Med. 2000;192(7):809–14.
17.
Zurück zum Zitat Bradley C. The diabetes treatment satisfaction questionnaire: DTSQ. In: Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice; 1994, pp. 111–32. Bradley C. The diabetes treatment satisfaction questionnaire: DTSQ. In: Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice; 1994, pp. 111–32.
18.
Zurück zum Zitat Fukuhara S, Suzukamo Y. Manual of the SF-8 Japanese version. Kyoto: Institute for Health Outcomes & Process Evaluation Research; 2004. p. 71–116. Fukuhara S, Suzukamo Y. Manual of the SF-8 Japanese version. Kyoto: Institute for Health Outcomes & Process Evaluation Research; 2004. p. 71–116.
19.
Zurück zum Zitat Bottomley A, Jones D, Claassens L. Patient-reported outcomes: assessment and current perspectives of the guidelines of the food and drug administration and the reflection paper of the European medicines agency. Eur J Cancer. 2009;45(3):347–53.CrossRefPubMed Bottomley A, Jones D, Claassens L. Patient-reported outcomes: assessment and current perspectives of the guidelines of the food and drug administration and the reflection paper of the European medicines agency. Eur J Cancer. 2009;45(3):347–53.CrossRefPubMed
20.
Zurück zum Zitat Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychol Bull. 1955;52(4):281–302.CrossRefPubMed Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychol Bull. 1955;52(4):281–302.CrossRefPubMed
Metadaten
Titel
The revalidation of the diabetes treatment-related quality-of-life (DTR-QOL) questionnaire in Japan
verfasst von
Hitoshi Ishii
Hyunchung Ray Kim
Bruce Crawford
Publikationsdatum
28.08.2018
Verlag
Springer Japan
Erschienen in
Diabetology International / Ausgabe 2/2019
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-018-0371-1

Weitere Artikel der Ausgabe 2/2019

Diabetology International 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.